Lauri Wendland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lauri Wendland has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Mikko Tenhunen
Comprehensive Cancer Center, Helsinki University Hospital (HUS) and University of Helsinki, Helsinki, Finland
3 shared publicationsTiina Seppälä
Comprehensive Cancer Center, Helsinki University Hospital (HUS) and University of Helsinki, Helsinki, Finland
3 shared publications- Liisa Porra
Comprehensive Cancer Center, Helsinki University Hospital (HUS) and University of Helsinki, Helsinki, Finland
2 shared publications - Emmi Kirjanen
Helsinki Univ Hosp HUS, Comprehens Canc Ctr, Haartmaninkatu 4, Helsinki 00290, Finland
1 shared publication - Jenna Tarvonen
A. Comprehensive Cancer Center, Helsinki University Hospital (HUS) and University of Helsinki, Helsinki, Finland
1 shared publication Liisa Porra
Comprehensive Cancer Center, Helsinki University Hospital (HUS), Haartmaninkatu 4, Helsinki, 00290, Finland
1 shared publication
Latest Publications
- Open Access
- 28 September 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 1326-1333
Properties of paraffin wax as a bolus material in accelerator-based boron neutron capture therapy
Background and purpose: Boron neutron capture therapy (BNCT) is targeted radiation therapy enabling cellular-level cancer treatment. With epithermal neutrons, the dose maximum typically occurs ~2 cm deep in tissue, challenging superficial tumor control. As in external beam radiation therapy, surface dose can be increased using a bolus. However, in BNCT, tissue equivalency is complex and strongly dependent on elemental composition. This study examined a paraffin wax bolus’s effect on the epithermal neutron beam in accelerator-based BNCT (AB-BNCT) and evaluated agreement between treatment planning system (TPS) calculations and measurements. Materials and methods: Beam characterization used the neutron activation method with gold and manganese foils. Due to its high cross-section for thermal neutrons, manganese activation serves as a surrogate for boron dose estimation. Irradiations were conducted in a 3D water tank and in a head-shaped phantom with 5 and 10 mm boluses. Dose calculation utilized the newly commissioned RayStation TPS with a Monte Carlo-based engine built on the GEANT4 toolkit. Results: Calculated and measured results agree within 5% accuracy in significant dose region (>50% dose). Near the surface and at greater depths, agreement remains within 10%. The bolus shifts the activation depth curve toward the surface by 4–13 mm depending on its thickness. Manganese surface activation increases from 30% without a bolus to ~70% and ~ 90% with 5 and 10 mm boluses, respectively. Interpretation: Paraffin wax effectively moderates neutron energy, making it a suitable bolus material for AB-BNCT treatments requiring increased surface dose.
- 28 September 2025
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 64, 1326-1333
Open AccessProperties of paraffin wax as a bolus material in accelerator-based boron neutron capture therapy
Background and purpose: Boron neutron capture therapy (BNCT) is targeted radiation therapy enabling cellular-level cancer treatment. With epithermal neutrons, the dose maximum typically occurs ~2 cm deep in tissue, challenging superficial tumor control. As in external beam radiation therapy, surface dose can be increased using a bolus. However, in BNCT, tissue equivalency is complex and strongly dependent on elemental composition. This study examined a paraffin wax bolus’s effect on the epithermal neutron beam in accelerator-based BNCT (AB-BNCT) and evaluated agreement between treatment planning system (TPS) calculations and measurements. Materials and methods: Beam characterization used the neutron activation method with gold and manganese foils. Due to its high cross-section for thermal neutrons, manganese activation serves as a surrogate for boron dose estimation. Irradiations were conducted in a 3D water tank and in a head-shaped phantom with 5 and 10 mm boluses. Dose calculation utilized the newly commissioned RayStation TPS with a Monte Carlo-based engine built on the GEANT4 toolkit. Results: Calculated and measured results agree within 5% accuracy in significant dose region (>50% dose). Near the surface and at greater depths, agreement remains within 10%. The bolus shifts the activation depth curve toward the surface by 4–13 mm depending on its thickness. Manganese surface activation increases from 30% without a bolus to ~70% and ~ 90% with 5 and 10 mm boluses, respectively. Interpretation: Paraffin wax effectively moderates neutron energy, making it a suitable bolus material for AB-BNCT treatments requiring increased surface dose.
- 22 May 2025
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 225, 111896
Neutron activation in interrupted neutron beams
- 22 May 2025
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 225, 111896
Neutron activation in interrupted neutron beams
- Open Access
- 4 July 2024
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1066
Effects of ionization chamber orientation in photon and neutron beams
- 4 July 2024
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1066
Open AccessEffects of ionization chamber orientation in photon and neutron beams